CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 189 enrolled
Drug / intervention
Prednisone +1 moredrug
Likely dose
Prednisone 40mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02330952
NCT02330952Phase 4Completed
CompareCT.gov

Efficacy and Safety of Oral Corticosteroids for the Treatment of Acute Exacerbations of COPD in General Practice

Assistance Publique - Hôpitaux de Paris·interventional·Posted Jan 5, 2015·Updated Sep 11, 2025

In Brief

A Phase 4 clinical trial evaluating Prednisone and Placebo for Pulmonary Disease and Chronic Obstructive (MeSH). Completed, enrolled 189 participants across 1 site.

Detailed Summary

Primary objective: The aim of this study is to determine the efficacy and safety of five days of oral corticosteroids (40 mg / day) for the treatment of acute exacerbations of COPD (AECOPD) in outpatients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPulmonary Disease, Chronic Obstructive (MeSH)
CountriesFrance
CollaboratorsURC-CIC Paris Descartes Necker Cochin

Timeline

Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedJan 5, 2015
Enrollment StartFeb 10, 2015
Primary CompletionMay 23, 2017
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 11.5 years ago

Interventions

Prednisonedrug

40mg/day per os for 5 days

Placebodrug

40mg/day per os for 5 days